• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Type 1 Diabetes 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Type 1 Diabetes trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Type 1 Diabetes research

Despite recent advances in the treatment of type 1 diabetes, there remains unmet need for effective treatment solutions for the children and adults living with this disease. Signant Health improves opportunities for study success by applying clinical research technologies in our Signant SmartSignals suite and scientific expertise to help researchers address barriers to success.

Why Signant Health

  • Collect Better Quality Data
  • Optimize Supplies Efficiently
  • Simplify Study Participation
  • Digitize the Process
  • Go Global With Hybrid Study Design
  • Collect Better Quality Data

    Collect Better Quality Data

    Signant SmartSignals eCOA helps study teams collect more high-quality data with less effort than paper-based alternatives. Plus, our research-grade blood glucose meters automatically transfer readings. The result is complete, accurate, and timely data without adding burden to patients’ routines.
     
     

  • Optimize Supplies Efficiently

    Optimize Supplies Efficiently

    With so many medications and devices used in type 1 diabetes studies, study teams need solutions to maximize efficiency without burdening sites. Signant’s RTSM system applies predictive algorithms to ensure optimal product allocation and usage. We can also deploy system and protocol amendments much faster than other solutions thanks to an innovative agile design process.

     

  • Simplify Study Participation

    Simplify Study Participation

    Managing type 1 diabetes is a daily effort, so we have built engagement solutions into our eCOA system to keep study participants on track and support caregivers. Interactive guides, easy access to study documents and contacts, customizable notifications, and video visits make participation easier.
     

  • Digitize the Process

    Digitize the Process

    Each solution and service within our Signant SmartSignals evidence generation platform can be applied to a study independently, but when combined, they create an intuitive digital ecosystem for creating and managing complex global studies. Plus, every study is supported by a dedicated team of clinical science and operations experts.
     

  • Go Global With Hybrid Study Design

    Go Global With Hybrid Study Design

    Global studies designed with decentralized technology elements can help expand the reach of type 1 diabetes studies while simplifying study conduct and participation. Signant’s software solutions, advisory services, and global operations infrastructure help sponsors design and conduct effective, efficient clinical trials.
     

Comprehensive Type 1 Diabetes experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Type 1 Diabetes trial resources
SOLUTION BROCHURE

Type 1 Diabetes Trial Solutions Overview


GET INSIGHTS
VIDEO

Type 1 Diabetes Trial Solutions


WATCH [2 MIN]
SOLUTION

Sensors and Wearables


 
LEARN MORE

eClinical solutions for Type 1 Diabetes trials

Ready to learn more?

Discover how Signant can support your current or upcoming Type 1 Diabetes trials. 

DOWNLOAD BROCHURE GET STARTED